On the contrary, Michalski et al. study showed hu210, a synthetic agonist of cannabinoid receptors cb1 and cb2, resolved the abdominal pain induced by AP and decreased the inflammation of the pancreas, shows therapeutic benefits of the pancreas [25]. Here, CNR1 is linked to alkaline phosphatase measurement.